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We selected peptide ligands mimicking the surface structure of discontinuous binding sites of Puumala hantavirus-
neutralizing monoclonal antibodies from a random 18-amino acid peptide library containing a disulfide bridge in a fixed
position and displayed on a filamentous phage. The varying of selection conditions, either by shortening of the association
time or by competitive elution with antigen, was crucial for the selection of peptide inserts that could be aligned with the
primary sequences of the envelope glycoproteins G1 and G2. Correspondingly, when the envelope glycoprotein sequences
were synthesized as overlapping peptides as spots on membrane, the same site in primary structure was found as with
phage display, which corroborates the use of the two methods in mapping of conformational epitopes. Also, epitopes reactive
with early-phase sera from Puumala virus infection were defined with the pepspot assay in the amino-terminal region of G1.
Similarities of the selected phage clones to a monoclonal antibody–escape mutant site and to a linear early-phase epitope
were found. © 1999 Academic Press
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aINTRODUCTION
Random peptide libraries expressed on phage have
een used in mapping of binding sites for antibodies and
ther proteins (Scott and Smith, 1990; Koivunen et al.,
994; Stephen et al., 1995; Prezzi et al., 1996; D’Mello et
l., 1997). In the case of linear epitopes, this often is a
elatively easy task. However, biologically significant an-
ibodies often recognize discontinuous or conformational
pitopes. The elucidation of the structure and the pri-
ary sequences of such epitopes would have dual pur-
oses: to be able to recreate the antibody activity by
mmunization and to form a hypothesis of the surface
tructure of the antigen (Chen et al., 1996). In practice,
his would mean the alignment of short stretches from
he antibody-binding sequence selected from a peptide
ibrary to different parts of the primary sequence, which
ould, in the native antigen, be brought together by the
ertiary structure. An additional aim would be to study
hether the possible function of an antigenic site could
e mimicked by antibody-binding peptide sequences.
he development of artificial vaccines directly mimicking
eutralization sites would overcome at least two prob-
ems: difficulties in production of large amounts of native
irus proteins and the fact that sometimes recombinant
roteins or even purified virus give an opposite effect
han expected when used in vaccination (i.e., enhance-
ent of disease). This has happened in vaccination trials
1 To whom reprint requests should be addressed at P.O. Box 21. Fax:
158-9-19126491. E-mail: Tuomas.Heiskanen@helsinki.fi.
321ith, for example, respiratory syncytial virus (Piedra et
l., 1997). The enhancement may be an indication of the
estruction of the neutralizing sites dependent on the
ative conformation of virus proteins during vaccine pro-
uction and could be avoided by direct immunization
ith a mimic of a neutralization site.
Puumala virus (PUU; genus Hantavirus, family Bunya-
iridae) is a good candidate for studies on the develop-
ent of artificial mimics of virus. There is no efficient
herapy or vaccine against hantaviruses, and they cannot
e easily grown in large quantities in cell culture. Han-
aviruses are enzootic in rodents, but humans are occa-
ionally infected, which may lead to two life-threatening
iseases. Hemorrhagic fever with renal syndrome
HFRS) is caused by Hantaan, Seoul, and Dobrava vi-
uses (Lee and Lee, 1976; Lee et al., 1990; Antoniadis et
l., 1996; Lundkvist et al., 1997) and hantavirus pulmo-
ary syndrome (HPS) by Sin Nombre (SNV) and related
iruses (Nichol et al., 1993; Hjelle et al., 1994). PUU is
arried by the bank vole (Clethrionomys glareolus) and is
he cause of nephropathia epidemica, a mild form of
FRS (Brummer-Korvenkontio et al., 1980). Hantaviruses
ave a negative-stranded RNA genome in three separate
egments, large (L), medium (M), and small (S), covered
y nucleocapsid protein (N). The L gene encodes the
iral RNA-polymerase/transcriptase, M; the two envelope
lycoproteins, G1 and G2; and S, the N (Schmaljohn et
l., 1985; Elliott, 1990; Vapalahti et al., 1992; Plyusnin et
l., 1996). The N protein of hantaviruses elicits an early
ntibody response (Arikawa et al., 1989; Lundkvist et al.,
993). G1-specific antibodies also appear in the acute
0042-6822/99 $30.00
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322 HEISKANEN ET AL.hase of at least SNV infections (Jenison et al., 1994;
jelle et al., 1997). High-titer antibodies against G1 and
2 emerge only later in PUU and Hantaan virus infec-
ions. Some epitopes in G2 are conserved between Han-
aan and PUU, whereas the epitopes in G1 are species
pecific (Chu et al., 1994). Monoclonal antibody (MAb)–
scape mutations have been found in both the Hantaan
1 and G2 regardless of the G1 or G2 specificity of the
Ab (Wang et al., 1993). We have previously shown with
UU neutralization site binding phage-displayed peptide
nserts that the neutralization sites in PUU G1 and G2 are
n close proximity of each other (Heiskanen et al., 1997).
his indicates that the conformational neutralization
ites in hantavirus G1 and G2 may form a continuous
urface. The glycoproteins and the N protein are impor-
ant for protection as shown by immunization experi-
ents. The best response is obtained when both glyco-
roteins are used in immunization. Immunization only
ith N also protects the natural hosts of PUU and Han-
aan viruses (Schmaljohn et al., 1990; Liang et al., 1996;
undkvist et al., 1996; Ulrich et al., 1998).
Here we show that it is possible to find peptide ligands
rom phage-displayed random peptide libraries with se-
uence similarities to the primary sequence of the orig-
nal antigen for MAbs recognizing conformational
pitopes if the phage selection is oriented toward the
imicry of binding kinetics of antigens and toward the
T
Sequences Selected with Puumala Virus Envelope Glycop
4G2 (Bank Vole, G2 Specifi
5A2 4G
iacore sensor chip 60 ng, micro
1) WGCVLHMVDDGRLGAVICGS 3 RGCIKKSDRPE
PMCSNRMADDIWSVPWYCVR 1 INCRIGTRLLRD
CWDDGWLC 4 ASCPVQQYPSG
SLCAGQVVFER
2) YLCHARAIDTTCIWPEPCFD 3 GPCVEERHWL
RLCSVSYPEPSLLWTSSCFD 1 LMCGWTMDPV
RLCAGGASLIEPVYALRCAE 1 LRCLGGHNESA
VACSYPEPYLSVAAGCNQ 1 ERCKMMVPGM
GHCALWTSPH
RMCLQCRIGSGCRAVLCAY 2
EQCWKLFPANCVGCATRCNA 1
DLCHLRKTEGIWAMHCV 1
6 ng, microtiter well
RMCLQCRIGSGCRAVLCAY 1
ng, microtiter well
RMCLQCRIGSGCRAVLCAY 5
EQCWKLFPANCVGCATRCNA 1
Note. Amount of MAb coated on microtiter well is shown above the s
g. The number of the sequenced clones from each coating concentra
equence.
(1) denotes the sequences that have in common the DD dipeptide a
(2) denotes the sequences with dipeptide EP in common and simila
est alignments to those sites are underlined.inding to exactly the same sites on antibody as antigen. MRESULTS
equences selected with neutralizing MAbs and their
eactivities in binding assays
Selection with MAb 5A2.This bank vole MAb neutral-
zes PUU in cell culture, immunoprecipitates G1, but does
ot recognize G1 in immunoblotting (Lundkvist and
iklasson, 1992; Lundkvist et al., 1993). Thus it has a
iscontinuous neutralizing epitope in envelope glycopro-
ein G1. The phage population selected by three rounds
f biopanning with MAb 5A2 in a microtiter well was
ubjected either to additional biopanning or to selection
n a biosensor. We found that these two methods gave
qual enrichment (30–35-fold) compared with control
Abs (PUU N-specific bank vole MAb 1C12 in biopan-
ing and PUU G2-specific bank vole MAb 5B7 in the
iosensor).
However, the microtiter well panning and biosensor
elected different phage populations. The mimotopic
ore structured sequence RMCLQCRIGSGCRAVLCAY,
aving probably two disulfide bridges, constituted 86% of
he sequence population obtained by only biopanning
ut only 12% of the sequences obtained by biosensor
election (Table 1). The biosensor-selected sequence
GCVLHMVDDGRLGAVICG in group 1 (Table 1) could
e aligned to amino acids 273–280 in envelope glyco-
rotein G1 (Fig. 1A), which contain the mutation in a 5A2
Specific Neutralizing MAbs 5A2 (Bank Vole, G1 Specific),
1C9 (Human, G2 Specific)
1C9
ell 4.4 ng, microtiter well
CGV 1 FPCDRLSGYWERGIPSPCVR 9
CWA 1 LYCLVYVPEVQTMYCDG 1
VCDT 1 CYCTRLHEDGSYAPTFYCLL 1
SQ 2 LYCISSGGKMKDASTVYCRN 1
ILCNR 1
TLTCTA 1
ECTP 1
LVCPM 1
LCGL 1
ced peptide inserts. The amount of MAb coupled to sensor chip is ;5
m microtiter well or from sensor chip is shown on the right side of the
e similarity to the site 273–280 in G1.
sites 61–71 and 264–267 in G1. The sequences in these groups withABLE 1
rotein
c), and
2
titer w
KRLASG
APAQV
PCEAS
TAARC
GRRDS
WGAW
SRRAI
TGSAA
FRIEAR
equen
tion fro
nd hav
rities toAb–escape mutant virus. The Asp2723 Val mutation
323DEFINITION OF PUUMALA VIRUS NEUTRALIZATION SITES
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324 HEISKANEN ET AL.s the only amino acid change needed to protect PUU
rom neutralization by MAb 5A2 (Ho¨rling and Lundkvist,
997). The other two DD-containing peptides (group 1)
re more mimotopic representatives of this site. Accord-
ng to the alignments, the dipeptide EP in the peptide
nserts RLCSVSYPEPSLLWTSSCFD and RLCAG-
ASLIEPVYALRCAE in group 2 could represent amino
cids 264–265 in G1 and SLLWTSSCFD the site 61–71
Fig. 1A). This may indicate proximate positions of these
ites in the tertiary structure of G1. Peptides YLCHARA-
DTTCIWPEPCFD and VACSYPEPYLSVAAGCNQ in group
represent in a more mimotopic way the EP site. The
equence YLCHARAIDTTCIWPEPCFD has properties of
oth groups, indicating the proximity of the defined bind-
ng sites in the surface structure of the virus.
The MAb 5A2-selected sequences bound specifically
o MAb 5A2, as shown by the reactivity of phage-derived
eptides synthesized on spots with MAbs 4G2 and 5A2
nd a pool of negative sera (Fig. 2). The phage sequence
LCSVSYPEPSLLWTSSCFD reacted most strongly with
Ab 5A2, whereas the more mimotopic sequence RM-
LQCRIGSCRAVLCAY and the previously selected fi-
ronectin-binding peptide CWDDGWLC, representing
he fibronectin- and vitronectin-binding sites of integrins
Pasqualini et al., 1995), were not reactive (Fig. 2). The
WDDGWLC phage has obviously contaminated the li-
rary at some point and was selected by MAb 5A2 on the
ame basis as the homologous peptide insert PMCSNR-
ADDIWSVPWYCVR, also having similarity to the bind-
ng site of the b3-integrin (amino acids 118–133, MDL-
YSMKDDLWSIQ; identical or similar amino acids are in
old). As a phage clone, the sequence RMCLQCRIG-
CRAVLCAY showed high reactivity toward MAb 5A2 but
lso cross-reacted equally with all tested MAbs (not
hown).
The binding site of neutralizing MAb 5A2 overlaps with
he defined early epitope in the amino-terminal region of
1. Sera from three patients with recent PUU infection
eacted with three N-terminal epitopes of G1 (i, ii, and iii;
ig. 1B). Pooled negative sera from 10 individuals did not
eact with these epitopes but reacted with some other
inear peptides (Fig. 1B; Table 2). The amino-terminal
pitopes ii and iii (residues 56–96) reacted with the
cute-phase sera. These epitopes overlap with the cor-
esponding region of SNV (residues 58–88; Hjelle et al.,
994; Jenison et al., 1997), reactive with acute-phase SNV
era. According to the pepspot assay, the most reactive
FIG. 1. (A) Alignment of the 5A2-specific sequences with the envelope
o an amino acid gap in the sequence of the peptide insert. The site of
s shown in bold. The peptide reacting most strongly in epitope ii with
nd S3b are underlined. (B) Reactivity of the IgG of two early convales
uman serum (S3b), and a pool of 10 negative sera (N) with peptides
lycoproteins G1 and G2. An arrow shows the position of the peptide S
equence (A). The epitopes/peptides reacting specifically with at least
umerals (i–vi).eptide in epitope ii with acute-phase serum S3b is
LKLESSCNFDL, which is also the putative binding site
f MAb 5A2. The terminal amino acids SLK and FDL (of
hich SL and FD are also present in the peptide insert
LCSVSYPEPSLLWTSSCFD reacting with MAb 5A2) are
ritical for reactivity of this peptide with serum S3b (Fig. 1B).
he first amino acids in G1 are part of an amino-terminal
pitope i recognized by serum S1b and vary between dif-
erent PUU isolates. The early sera S2b and S3b do not
eact with epitope i, which may be due to variability either
n the sequence or in the antibody response. In epitopes ii
nd iii, there also are variable residues.
rotein G1. u, Identical amino acid; 1, similar amino acid; 2, corresponds
y amino acid change in 5A2-selected MAb–escape mutant (D2723 V)
rum S3b and the epitope iii having reactivity with early sera S1b, S2b,
hase sera (S1b and S2b) from PUU-infected patients, an acute-phase
nting as spots on membrane the primary sequence of the envelope
SCNFDL that can be aligned with the MAb 5A2-selected phage insert
sted serum are boxed in each serum assay and marked with Roman
FIG. 2. Phage-displayed peptide inserts were synthesized on spots
n membranes, and their reactivities with PUU neutralizing MAbs 5A2,
G2, and 1C9 and with PUU-negative sera pooled from 10 serum
amples (N) were tested. The figure shows reactivity of peptides selected
ith MAb 5A2(A) or 4G2(B). The X-ray film was exposed for 1 min.glycop
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325DEFINITION OF PUUMALA VIRUS NEUTRALIZATION SITESSequences selected with MAb 4G2. A competitive elu-
ion by antigen of the bound phages from the antibody
as applied for neutralizing bank vole MAb 4G2, which
mmunoprecipitates PUU G2 and, weakly, G1 and has a
iscontinuous epitope overlapping the discontinuous
pitope of the PUU G2-specific neutralizing human MAb
C9 (Lundkvist and Niklasson, 1992; Lundkvist et al.,
993). The usual panning procedure produced only a
ontaminating cross-reactive sequence RMCLQCRIG-
CRAVLCAY, also seen in the panning with MAb 5A2. In
he panning round after competitive elution, at least 10
imes more phages were eluted by low pH from 60 ng of
Ab 4G2, whereas no phages were detected from the
ontrol well. The peptides ASCPVQQYPSGPCEASVCDT
nd ERCKMMPGMTGSAALVCPM reacted with MAb 4G2
n spots (Table 1; Fig. 2). Interestingly, ASCPVQQYPSG-
CEASVCDT reacted equally well with neutralizing G2
pecific MAb 1C9 and with MAb 4G2, whereas no reac-
ivity was observed with MAb 5A2 or with PUU-negative
uman sera (Fig. 2). In contrast, ERCKMMPGMTG-
AALVCPM did not react with 1C9 (Fig. 2). When both of
hese reactive sequences were compared with linear
eptides derived from PUU G1 and G2 (strain Sotkamo),
hich are reactive with MAbs 4G2 and 1C9 (Fig. 3A), we
oticed that ASCPVQQYPSGPCEASVCDT could easily be
ligned with the linear peptide, which is most reactive
ith 4G2 and also reacts with 1C9 (Fig. 3B). Correspond-
ngly, the peptide ERCKMMPGMTGSAALVCPM could be
ligned with a linear peptide that reacts with 4G2 but not
ith 1C9 (Fig. 3B). The alignment of the two linear 4G2-
eactive sequences TTPVCQF and DTKCSSTGLVAA with
he 4G2-selected phage sequences shows that these
T
Linear 12-Amino Acid Peptides from Envelope Glycoproteins G
Convalescence (S1b and S2b) and One A
Peptides Reactivity
FDTVNAKNLNEL 11
VNAKNLNELKME 11
PPVPIQQIESLK 1
PIQQIESLKLES 1
QIESLKLESSCN 1
SLKLESSCNFDL 11
QQSFTKWTWETK 11
FTKWTWETKGDL 11
WTWETKGDLAEN 1, 11, 11
ETKGDLAENTQA 11, 11
TVYCNGVKKVIL 11
SALEWIDLDSSL 11, 11
SSLRDHINVIVS 11, 11
Note. Residues most probably involved in the reactivity with sera arites are most probably direct binding sites for the MAb sG2 and that the TTPVCQF site in G2 (residues 918–926)
s also a binding site of MAb 1C9 (Fig. 3B).
The neutralizing G2-specific MAbs 1C9 and 4G2 gave
ather similar patterns in probing the linear peptides of
1 and G2 in the pepspot assay, although they have only
artly overlapping epitopes (Lundkvist and Niklasson,
992), whereas MAb 5A2 gave almost no reaction (Fig.
A). In most cases, the intensity of the reactions and the
ength of the reacting regions varied. The most clearly
eacting peptides are listed in Table 3.
Sequences selected with MAb 1C9 and their reactivi-
ies on membrane. After the third panning round, the
hages bound to 4.4 ng of MAb 1C9 67 times over the
ackground. The sequence FPCDRLSGYWERGIPSPCVR
onstitutes 75% of all the sequences selected with MAb
C9 (Table 1), and it gave the best alignment to a site
31–934 in G2 near the defined MAb–escape mutant site
or MAb 1C9 (Fig. 3B). According to its reactivity as
ynthesized on spot, its affinity toward its ligand antibody
s by far the highest compared with all other sequences
robed on membrane (Fig. 4A). In a few seconds, it gave
very high reaction compared with other sequences that
equired at least a 1-min exposure to become visible in
he same assay (Fig. 4A). The sequence was highly
pecific for 1C9 as shown by the absence of binding of
ther MAbs to the biotinylated peptide bound to strepta-
idin plate (Fig. 4B). The peptide inhibited at least par-
ially the binding of all the sequenced 1C9 binding phage
lones (Fig. 4C), which indicated that despite the great
equence diversity, these peptides reacted with a site in
he antibody molecule overlapping with the binding site
f FPCDRLSGYWERGIPSPCVR. The peptide bound to the
2 (PUU, Strain Sotkamo) Reacting Specifically with Two Early
ase (S3b) Nephropathia Epidemica Sera
Reacting sera Epitope and its position
S1b FDTVNAKNLNELKME
S1b 19–33
S3b PPVPIQQIESLKLESSCN
S3b FDL, 52–72
S3b
S3b
S2b QQSFTKWTWETKGDL,
S2b 79–93
S2b,S1b,S3b WTWETKGDLAENTQA,
S1b,S3b 85–99
S1b TVYCNGVKKVIL,
442–453
S1b,S3b SALEWIDLDSSL,
946–957
S1b,S3b SSLRDHINVIVS,
955–966
rlined.ABLE 2
1 and G
cute Phame site (paratope) in 1C9 that is involved in MAb–virus
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326 HEISKANEN ET AL.inding, as shown by the inhibition of the binding of the
Ab to the virus coated on microtiter wells (Fig. 4D). This
urther showed that the peptide had a high affinity toward
Ab 1C9 in liquid phase.
DISCUSSION
ffect of the binding kinetics and the competitive
lution with antigen on the selection of
ntibody-binding peptide inserts
The real epitopes recognized by natural antibodies
erived from infected organisms are mostly surface
tructures of proteins, whereas linear peptides com-
only recognized by antibodies may constitute parts of
onformational epitopes. Crystallographic studies on an-
igen–antibody complexes have shown that antibodies
ay form direct contacts with 14–22 amino acids and
hat two to five continuous polypeptide segments consti-
ute the binding region on the antigen (Davies and Pad-
an, 1991). The conformationality of an epitope is, thus, a
atter of degree. The purpose of selecting peptides from
andom libraries displayed on phage with neutralizing
ntibodies is to define binding sites on antigen and to
ind peptide inserts that would resemble as much as
ossible the real antigen. According to competition of
hage binding with MAb 1C9 by the synthetic peptide
PCDRLSGYWERGIPSPCVR, quite different-looking pep-
ides may bind to the same site. This may reflect the fact
hat an anti-idiotype also has different contacts to the
omplementarity-determining regions of the antibody
CDRs) as the real antigen (Bentley et al., 1991). CDRs
ay have many different conformations that are in ther-
odynamic equilibrium, and each phage clone may bind
o its own conformation (Davies and Padlan, 1990). One
easure of success of the phage-peptide selection by
Abs would then be the sequence similarity of the
elected clones to short linear peptides derived from the
inear sequence of antigen and the recognition of these
eptides by neutralizing MAbs despite the conformation
f their epitopes. It has been shown that in some cases,
he MAbs with conformational epitopes can still recog-
ize short linear epitopes (Roivainen et al., 1991) due to
igh sensitivity of detection as suggested by Van Regen-
ortel (1988, 1992).
We studied the effect of different conditions on the
election of phage-displayed peptides and conclude that
n addition to the used peptide library and the target
olecule, the association time and the way of elution
ave an influence. According to Stephen et al. (1995),
onger peptide inserts produce sequences that are more
omologous to the original antigen, which is in agree-
ent with our results. The amount of possible binding
ites available in the library increases because the dis-
ance between key amino acids involved in binding can
e substantially longer than, for example, in a 6-amino
cid-long library, although the amount of clones is at the aame level as in libraries with smaller peptide inserts.
he competitively eluted sequence ASCPVQQYPSGP-
EASVCDT was also recognized by an MAb other than
he one used for selection. The antigen could elute com-
etitively from a CDR most easily those peptide se-
uences that have bound to the same site as the antigen
ith same contacts. The conformation of the CDR would
lso be the same in contact with these peptides as in
ontact with the real antigen. In the biosensor, the se-
uences are selected based on a short association time.
his means that those sequences are selected that bind
o the most usual conformation of the antibody and
hose binding demands the least amount of energy. This
s in contrast to selection in a microtiter well where the
ssociation time can be long and the sequence may be
elected by a long dissociation time. This corresponds to
he selection of sequences whose binding may cause an
nergy-demanding conformational switch and that do
ot easily detach from the selecting molecule. Selection
ith a biosensor may define especially those residues in
ntigen that are involved in the initial recognition by an
ntibody. The effective phage selection in vivo in blood
essels resembles the situation in a biosensor (Pas-
ualini and Ruoslahti, 1996). Also, the movement of an-
ibody molecules is more free in the sensor chip than in
he microtiter well. Prezzi et al. (1996) reported better
esults with panning with antibodies captured with Fc-
pecific Fab than with an antibody coated directly onto
olystrene beads.
he definition of neutralization sites of PUU and sites
ecognized by the early immune response to PUU
Our results agree with previous epitope mapping and
haracterization of antigenic sites of hantaviral glyco-
roteins (Arikawa et al., 1989; Wang et al., 1993; Hjelle et
l., 1994; Kikuchi et al., 1998). The defined binding site
LKLESSCNFD of MAb 5A2 is near the MAb–escape
utation site of Hantaan virus G1-specific neutralizing
Ab 16D2 found by Kikuchi et al. (1998), and the epitope
ii contains this site (Fig. 1A). The epitopes ii and iii
ecognized by acute-phase sera are in the area (amino
cids 56–96) corresponding to an immunodominant
pitope in the amino-terminal region of SNV G1 (amino
cids 59–89; Hjelle et al., 1994). The variability of this
egion of PUU fits with its dominant antigenicity. It ap-
ears to be important for PUU to evade the immune
esponse directed to this region. The individual reactive
eptides iv and v also show some variability between
UU isolates. The previously created 16D2 MAb–escape
utants locate to both sides of the MAb–escape mutant
ite of MAb 5A2 and to the EP site (amino acids 264–265)
efined by phage display (Wang et al., 1993; Ho¨rling and
undkvist., 1997). The binding of Hantaan G2 specific
on-neutralizing MAbs required that beginning from the
mino-terminus, 80% of G2 is expressed (Wang et al.,
327DEFINITION OF PUUMALA VIRUS NEUTRALIZATION SITES
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328 HEISKANEN ET AL.993). The reacting peptides v and vi in G2 (Fig. 1B), also
s epitope mapping of MAb 1C9, fit to the carboxyl-
erminal part of this area (Fig. 3B; Ho¨rling and Lundkvist,
997).
The MAb 5A2 did not react with the epitope ii in
epspot assay (Fig. 3A) despite the similar phage clone
elected by MAb 5A2. This implies that in the beginning
f PUU infection, some antibody clones are able to rec-
gnize this linear epitope, but in the course of affinity
aturation, the specificity of antibody clones increases,
nd they lose this ability. These potentially protective
ntibodies do not lose this epitope, but their way of
ecognition changes toward conformations in old-immu-
ity patients. Hjelle et al. (1997) reported that immunity
oward the linear immunodominant peptide of SNV G1
sually vanishes 8 months after infection. Interestingly,
Ab 5A2 binds putatively to a site in this immunodomi-
ant region that is more conserved between PUU and
NV than other parts of the immunodominant epitope of
NV. PUU is more related to SNV than other HFRS-
ausing hantaviruses (Jenison et al., 1994). The site SLK-
ESSCNFDL may be of functional importance because it
s both antigenic and conserved, but on the other hand,
he neutralizing antibody response is hantavirus species
TABLE 3
Linear 12-Amino Acid Overlapping Peptides from Envelope Glyco-
roteins G1 and G2 (PUU, Strain Sotkamo) Reacting with Neutralizing
2-Specific MAbs 1C9 and 4G2
Peptide 4G2 1C9
Amino acid
position
YDLSCNQTVCQ 11 11 136–147
QKTGCTANGFQ 11 241–252
YECETAKELES 11 1 559–570
PWQTAGCFVEK 11 1 754–765
ETGWGCNPPDC 11 11 769–792
WGCNPPDCPGV 11 11
NPPDCPGVGTG 11
DCPGVGTGCTA 11
GVGTGCTACGV 11
TCKTVDSNDCL 11 111 822–834
CAFATTPVCQF 111 1 914–931
ATTPVCQFDGN 111 1
PVCQFDGNTIS 111 1
TKCSSTGLVAA 11 1057–1068
Note. 111, Clearly reacting; 11, reacting; 1, reacting over back-
round.
FIG. 3. (A) Reactivity of the PUU-neutralizing MAbs with the peptides
membrane. The detecting MAb is shown in the top left. The X-ray
G2-selected peptides (B) expressed on phage are boxed (1 and 2). (
nvelope glycoprotein G2. u, Identical amino acid; 1, similar amino acid
r G2. The epitope 1 recognized by 4G2 and 1C9 and the epitope 2 reco
cid stretch common for all overlapping peptides. The only amino acid c
djacent epitope reacting with the sera S1b and S3b is underlined.pecific and, thus, the neutralizing epitopes should con-
ist at least partly of variable residues. The epitope
ecognized by MAb 5A2 has been shown to be immuno-
ominant (Lundkvist et al., 1992). Our evidence indicates
hat the region consisting of amino acids 55–96 of G1
early overlapping with the immunodominant region of
NV is also immunodominant in PUU infection but that
he reactivity of linear peptides derived from this area
ay be lower than in SNV, probably because the region
s more conformational in PUU, and that the epitopes of
eutralizing antibodies may overlap this region. Another
rea that seems to have epitopes recognized by neutral-
zing antibodies and early-phase sera consists of PUU
2 amino acids 918–966.
onclusions and prospects
In summary, we have found mimotopic peptides bind-
ng to PUU-neutralizing MAbs and have used an inde-
endent method, pepspot analysis, to further define an-
igenic sites of PUU and to confirm the results of the
pitope mapping by phage display. The MAb–escape
utant studies are in accordance with our results. We
ave shown that variation of selection conditions by
imitation of association time and by competitive elution
s helpful in obtaining a broader view of the epitope of an
ntibody. The mimotope peptides and linear binding
ites we have found may provide useful starting points
or the study of the surface structure antigenic sites; for
he study of immune response toward these sites, func-
ions of PUU glycoproteins; and for vaccine development.
econdary phage libraries formed by these sequences
ight be valuable tools for these studies. It might be
ossible to find with the aid of a semirandom library
Puntoriero et al., 1998) based on the sequence of the
mmunodominant area of PUU G1 a set of peptide inserts
esembling more the structure of this site of PUU G1 and
eacting more strongly and more broadly with PUU
train-specific antibodies than linear peptides from this
rea.
MATERIALS AND METHODS
onoclonal antibodies
Bank vole and human MAbs were produced and pu-
ified as previously described (Lundkvist and Niklasson,
992; Lundkvist et al., 1993a).
ng the primary sequence of PUU G1 and G2 synthesized as spots on
as exposed for 5 min. The linear peptides that can be aligned with
ment of 4G2-reactive clones and one 1C9-reactive phage clone with
rresponds to an amino acid gap in the sequence of the peptide insert
by only 4G2 are double-underlined. The epitope is defined as an amino
in 1C9-selected MAb–escape mutant is S9443F (shown as bold). Thecoveri
film w
B) Align
; 2, co
gnized
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The serum samples S1b and S2b were collected from
atients 1 month after PUU infection (S1b 26 and S2b
5d). Serum S3b was obtained from a patient who had
een diagnosed as seronegative 6 days earlier. A pool of
0 PUU-negative sera was used as a control.
eptide library
The X2CX14CX2 random library was expressed at the
mino-terminus of each of the five copies of the pIII
rotein on the filamentous phage fd-tet (Scott and Smith,
990).
ynthetic peptides
Peptides synthesized as spots on derivatized cellulose
embranes. The protein sequence of the M segment of
FIG. 4. (A) 1C9-selected sequences were synthesized on spots and p
as superior to the other clones selected by 1C9. FPCDRLSGYWERG
eptide. The peptides LYCISSGGKMKDASTVYCRN (5) and LYCLVYVPE
escence-developed film). (B) Reactivity of PUU-specific MAbs with b
hree absorbance values 6 SD). (C) The effect of the synthetic peptide
lones to MAb 1C9. , FPCDRLSGYWERGIPSPCVR. M, LYCISSGGKM
mean of three absorbance values 6 SD). (D) The peptide FPCDRLSGY
f different concentrations of MAb 1C9 to PUU in the absence of peptid
alues 6 SD).UU (strain Sotkamo) was synthesized (Abimed Auto- upot robot ASP 222) on cellulose membrane as 380
2-amino acid-long peptides on a single membrane with
3-amino acid overlap. Also, some of the sequences of
hage clones selected with PUU neutralizing MAbs were
ynthesized on membranes.
Soluble peptides. Cyclic phage sequence-derived pep-
ides were synthesized and biotinylated when needed
ith a 433A Peptide Synthesizer (Applied Biosystems),
yclized with dimethylsulfoxide (Domingo et al., 1995)
nd purified by reverse-phase chromatography. The
uality of the peptides was assessed by mass spectro-
hotometry.
iopanning
Selection with MAb 5A2. Three rounds of biopanning
ere carried out as previously described (Koivunen et al.,
993; Smith and Scott, 1993; Heiskanen et al., 1997),
with 1C9. The reactivity of the phage clone FPCDRLSGYWERGIPSCVR
R (spots 1–4; 2–4, the Cys3 Ala mutations) reacts most strongly as
CDG (6) react more weakly (1-min exposure of enhanced chemilumi-
ted FPCDRLSGYWERGIPSCVR on streptavidin-coated plate (mean of
RLSGYWERGIPSCVR on the binding of the other 1C9-selected phage
TVYCRN. , CYCTRLHEDGSYAPTFYCLL. 3, LYCLVYVPEVQTMYCDG
IPSCVR inhibits the binding of MAb 1C9 to PUU-coated wells. Binding
nd in the presence of 0.3 mM peptide () (mean of three absorbancerobed
IPSPCV
VQTMY
iotinyla
FPCD
KDAS
WERG
e (f) ander different conditions. In each panning round, the
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330 HEISKANEN ET AL.igh-affinity phages from the well coated with the lowest
oncentration of MAb still giving at least 10 times more
hages than identically treated control well were ampli-
ied and used for the next round. In the first round, a
icrotiter well was coated with 2 mg of MAb 5A2 in PBS,
H 7.4, blocked with 1% BSA in PBST (PBS with 0.05%
ween 20). An aliquot from a library expressed on the
mino-terminus of the pIII protein of the phage fd-tet
ontaining the 18-amino acid disulfide-bridged random
nsert X2CX14CX2 was allowed to react with MAb 5A2 for
h at room temperature in Dulbecco’s salt solution (DBS)
upplemented with 0.05% Tween 20 and 1% BSA. The
ell was extensively washed with DBS with 0.05% Tween
0 (DBST) and 30 min at 37°C with the bank vole anti-
UU N MAb 5E1. The bound phages were eluted with 0.1
HCl–glycine, pH 2.2, containing 1 mg/ml BSA, and the
ells were incubated directly with 100 ml of K91KAN
acteria for infection by the remaining phages to occur.
he elution and the direct infection removed 6.3 times
ore phages than the wash with MAb 5E1. In the second
ound, the phages were allowed to attach for 1 h; 1 mg of
A2 gave 27 times more phages than background. In the
hird round, a well coated with 11 ng of 5A2 bound 75
imes more phages than background, and 900 ng of 5A2
ound 59 times more than MAb 5E1. In the fourth round,
he amplified phages were either injected to the biosen-
or (BIAcore 2000) in HBS buffer (10 mM HEPES, pH 7.4,
50 mM NaCl, 3 mM EDTA, 0.005% Surfactant P20) or
anned on a microtiter well as described above. In the
iosensor, the phages flowed first through a sensor chip
o which MAb 5A2 was coupled and then through a
ontrol sensor chip to which MAb 5B7 was coupled
about 5 ng of each antibody). The phages were first
luted with 10 mM acetic acid, pH 3.0, and then with 10
M glycine–HCl, pH 1.8.
Selection with MAb 4G2. A 180-ml sample containing a
0-ml aliquot of the X2CX14CX2 library in PBS and 80 ml of
BST/1% BSA was prepared in which the molarities of
aCl, KCl, and EDTA and the percentage of Triton-X 100
ere adjusted to correspond to the virus antigen buffer
150 mM NaCl, 600 mM KCl, 5 mM EDTA, 2% Triton X-100)
iluted 1:1 with PBS. The sample was allowed to react for
h at 37°C with 60 ng of MAb 4G2 coated on a microtiter
ell blocked with 1% BSA in PBS. The microtiter well was
xtensively washed with virus antigen buffer diluted 1:1
n PBS, including two 20-min washes at 37°C. The
hages were finally eluted competitively with the virus
ntigen (in virus antigen buffer) diluted 1:1 to PBS for 40.
he phages were very poorly amplified. The second
ound of panning was similar to the first three panning
ounds with MAb 5A2. The panning reaction was done in
% BSA PBST in the presence of 3 mg/ml MAb 5E1.
Selection with MAb 1C9. The selection with MAb 1C9
as done essentially as described above for the first
hree rounds with MAb 5A2 except that negative serum
n the liquid phase was used to compete the binding of fhages to 1C9 in the two first panning rounds and the
ime for binding was reduced to 30 min in the third (last)
anning round.
inding assays
Reactivity of MAbs with peptides synthesized on spots
n membrane. The membranes were activated accord-
ng to the instructions (Genosys Biotechnologies)
locked for 1 h or overnight with TBST (Tris-buffered
aline, pH 8.0, 0.05% Tween 20) containing 10% blocking
uffer concentrate (Genosys) and 5% (w/v) sucrose on a
haker at room temperature. The bank vole and human
Abs were diluted to 5 mg/ml in blocking buffer, and the
embranes were incubated for 3 h (MAb 5A2) or 1 h
MAbs 1C9 and 4G2), after which the membranes were
ashed five times for 5 min in TBST. Horseradish perox-
dase (HRP)-conjugated anti-mouse and anti-human sec-
ndary antibodies (DAKO) were diluted in blocking buffer
ccording to the manufacturer’s instructions. After a 30-
in incubation and five 5-min washes in TBST, the anti-
ody reactivity was determined with enhanced chemilu-
inescence: the membrane was dipped for 30–50 s in
:1 mixed substrate solution (solution 1: 2.5 mM 3-amin-
phtholhydrazide, 400 mM p-coumaric acid, 100 mM
ris–HCl, pH 8.5; solution 2: 0.018% H2O2, 100 mM Tris–
Cl, pH 8.5). The membranes were exposed on X-ray
ilms for 5 min.
Reactivity of sera from PUU-infected patients with pep-
ides synthesized on spots on membrane. The reactivity
as determined as described above except that serum
ere diluted 1:1000 and the reaction time of the mem-
rane with the diluted serum was reduced to 30 min. The
embranes were exposed on X-ray films for 1 min.
Binding of selected phage clones to MAbs. The bind-
ng of phage clones and the competition of binding by
eptides were assayed essentially as described by en-
yme immunoassay (Koivunen et al., 1994; Heiskanen et
l., 1997).
Binding of MAbs to biotinylated peptides on a strepta-
idin plate. The biotinylated peptide (50 mM in PBST) was
ncubated for 1 h on a ready-made streptavidin-coated
late (MicroCoat). After removal of unbound biotinylated
eptide by PBST washes, the wells were allowed to react
ith bank vole and human MAbs diluted to 10 mg/ml in
BST containing 0.2% BSA for 1 h at 37°C. The HRP-
onjugated secondary antibodies were diluted in DBST
.2% BSA, and the detection was performed as described
Heiskanen et al., 1997) except that the incubation time of
he o-phenylenediamine dihydrochloride substrate was
nly 5 min.
Competition of the binding of MAbs to PUU particles
y synthetic peptides. Microtiter wells (Nunc) were
oated with sucrose gradient-purified PUU diluted 1:50 in
BS for 1 h at 37°C and blocked with 0.1% BSA in PBSTor 30 min followed by washing. A constant concentration
o
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331DEFINITION OF PUUMALA VIRUS NEUTRALIZATION SITESf the peptide was allowed to react with dilution series of
Ab in DBST overnight at 4°C in 1.5-ml microtubes. A
ontrol contained the same concentrations of MAb in
BST only. The MAb–peptide mixtures and controls were
ncubated in virus-coated wells for 40 min at 37°C. The
ells were washed five times with DBST, after which the
eactivity of different MAb concentrations and the effect
f the peptide were detected by an appropriate HRP-
onjugated secondary antibody (DAKO) and by o-phen-
lenediamine dihydrochloride substrate.
equence alignments
A program calculating the N-best local alignments
etween two sequences (Nimes, France) was used to
ind the alignments between the sequences of the phage
lones and PUU.
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